International CSRC Investment Holdings Co. Ltd. AI Stock Analysis
International CSRC Investment Holdings Co. Ltd. (2104) AI Stock Analysis
International CSRC Investment Holdings Co. Ltd.
(TWSE:2104)
International CSRC Investment Holdings scores near the bottom of the range, driven primarily by severely deteriorating financial performance: falling revenue, negative gross and operating margins, a widening NT$4.1 billion net loss, and a third straight year of equity erosion alongside rising debt. Cash generation remains insufficient, with free cash flow negative for a second year despite an improvement in operating cash flow. Technicals reinforce the caution, as the stock trades below all key moving averages with negative MACD, though oversold RSI and Stochastic readings hint at possible near-term stabilisation. Valuation provides no offset, with a negative P/E and no dividend. The main sources of resilience are a still-serviceable capital structure, meaningful revenue scale that could deliver operating leverage if chemical margins recover, and a narrowing cash burn — but a clear cyclical turn is needed before the outlook improves.
International CSRC Investment Holdings Co. Ltd. (2104) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- TWD 9.94B
- Dividend Yield
- ―
- Average Volume (3M)
- 4.09M
- Price to Earnings (P/E)
- -2.0
- Beta (1Y)
- 0.59
- Revenue Growth
- -13.19%
- EPS Growth
- 45.83%
- Country
- TW
- Employees
- 1,537
- Sector
- General
- Sector Strength
- 55
- Industry
- Chemicals - Specialty
International CSRC Investment Holdings Co. Ltd. Business Overview & Revenue Model
Company Description
International CSRC Investment Holdings Co., Ltd. (2104.TW) is a Taiwan-based company that specializes in the global production and distribution of carbon black. This critical material is extensively used in the manufacturing of tires and various othe...
International CSRC Investment Holdings Co. Ltd. Financial Statement Overview
Summary
Very weak. Revenue has fallen to roughly NT$15.3 billion, down about 15% year-over-year and nearly 38% from the 2021 peak, while gross margin has collapsed from 28.2% in 2021 to -5.9%, meaning product is being sold below production cost. Operating margin is -14.5% and the net loss widened to about NT$4.1 billion (-27.1% margin), the third consecutive loss-making year. The balance sheet is the relative bright spot — equity of about NT$24.1 billion still funds roughly half of the NT$49.2 billion asset base — but equity has shrunk about 28% in two years while debt rose to NT$16.1 billion, lifting debt-to-equity to 0.67x from 0.41x in 2021, and ROE is deeply negative at -17.2%. Cash flow showed a tentative green shoot, with operating cash flow turning positive at about NT$533 million versus an outflow a year earlier, but after roughly NT$1.07 billion of capex, free cash flow remained negative at about -NT$542 million, a second straight year of burn that must be funded with additional debt.
Income Statement
12Very NegativeBalance Sheet
40NegativeCash Flow
32Negative| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 13.84B | 15.33B | 18.06B | 17.88B | 23.37B | 24.62B |
| Gross Profit | -1.49B | -909.37M | 900.63M | 1.47B | 3.27B | 6.94B |
| EBITDA | -1.91B | -806.73M | 901.01M | 1.91B | 3.26B | 6.60B |
| Net Income | -4.91B | -4.15B | -2.71B | -494.44M | 679.38M | 3.40B |
Balance Sheet | ||||||
| Total Assets | 48.20B | 49.19B | 54.80B | 56.84B | 58.41B | 57.51B |
| Cash, Cash Equivalents and Short-Term Investments | 14.89B | 14.81B | 14.32B | 16.83B | 18.40B | 19.83B |
| Total Debt | 16.48B | 16.07B | 13.56B | 13.68B | 15.13B | 13.64B |
| Total Liabilities | 24.07B | 23.68B | 21.43B | 21.38B | 22.85B | 22.29B |
| Stockholders Equity | 23.03B | 24.13B | 31.55B | 33.57B | 33.63B | 33.46B |
Cash Flow | ||||||
| Free Cash Flow | -646.82M | -541.65M | -1.49B | 2.02B | -2.40B | 484.01M |
| Operating Cash Flow | 556.41M | 532.89M | -493.25M | 3.06B | 761.46M | 3.85B |
| Investing Cash Flow | -270.97M | 644.86M | 1.59B | -8.06B | 2.07B | -4.28B |
| Financing Cash Flow | 2.53B | 2.63B | -1.94B | -2.18B | 701.30M | 3.86B |
International CSRC Investment Holdings Co. Ltd. Peers Comparison
Overall Rating
TW:650969Neutral
TW:473946Neutral
TW:470745Neutral
TW:172739Underperform
TW:210439Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 69Neutral | TWD 9.02B | 12.96 | ― | 3.23% | 2.00% | 57.23% | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| 46Neutral | TWD 8.41B | 13.42 | ― | 1.41% | 98.05% | 725.72% | |
| 45Neutral | TWD 11.15B | 21.39 | ― | 0.92% | -9.16% | 67.21% | |
| 39Underperform | TWD 11.75B | 121.53 | ― | 0.18% | 20.16% | 962.24% | |
| 39Underperform | TWD 9.80B | -2.04 | ― | ― | -13.19% | 45.83% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| TW:2104 | International CSRC Investment Holdings Co. Ltd. | 10.35 | 0.30 | 2.99% | |
| TW:1727 | Chung Hwa Chemical Industrial Works Ltd. | 84.10 | 47.51 | 129.83% | |
| TW:4707 | Pan Asia Chemical Corp. | 27.30 | 17.85 | 188.80% | |
| TW:4739 | Coremax Corporation | 71.00 | -0.53 | -0.74% | |
| TW:6509 | Taiwan Hopax Chemicals Manufacturing Co. Ltd. | 43.20 | 10.94 | 33.93% | |
| TW:7763 | Johnson Fine Chemical Co Ltd | 141.50 | 66.66 | 89.07% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 09, 2026
